![](/img/cover-not-exists.png)
Superior outcome after neoadjuvant chemotherapy with docetaxel, anthracycline, and cyclophosphamide versus docetaxel plus cyclophosphamide: results from the NATT trial in triple negative or HER2 positive breast cancer
Chen, Xiaosong, Ye, Guolin, Zhang, Chenfang, Li, Xinzheng, Chen, Yiding, Xie, Xiaohong, Zheng, Hong, Cao, Yali, Wu, Kejin, Ni, Duo, Tang, Jinhai, Wei, Ziguo, Shen, KunweiVolume:
142
Language:
english
Journal:
Breast Cancer Research and Treatment
DOI:
10.1007/s10549-013-2761-1
Date:
December, 2013
File:
PDF, 439 KB
english, 2013